Generic, Brand-Name Medication Similarly Effective for COPD
MONDAY, Aug. 7, 2023 -- For patients with chronic obstructive pulmonary disease (COPD), generic and brand-name fluticasone-salmeterol are similarly effective and safe, according to a study published online Aug. 8 in the Annals of Internal... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - August 7, 2023 Category: Pharmaceuticals Source Type: news
Generic Fluticasone –Salmeterol Inhaler for COPD Matches Branded Product
(MedPage Today) -- A generic fluticasone-salmeterol (Wixela Inhub) maintenance inhaler was clinically equivalent to name-brand Advair Diskus for chronic obstructive pulmonary disease (COPD), a propensity score-matched cohort study found.
With... (Source: MedPage Today Primary Care)
Source: MedPage Today Primary Care - August 7, 2023 Category: Primary Care Source Type: news
Lannett Signs Agreement To Be Exclusive Distributor Of Generic Flovent(R) Diskus(R)
Company Extends Distribution Term for Generic ADVAIR DISKUS®
PHILADELPHIA, Aug. 17, 2020 -- (Healthcare Sales & Marketing Network) -- Lannett Company, Inc. (NYSE: LCI) today announced that it has entered into an exclusive U.S. distribution agreemen... Biopharmaceuticals, Generics, Distribution Lannett Company, Flovent, Diskus, Fluticasone Propionate Powder Inhaler (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - August 17, 2020 Category: Pharmaceuticals Source Type: news
Cipla submits application with USFDA for generic version of asthma drug
Drug major Cipla on Monday said it has submitted an application with the US health regulator for a generic version of GSK's Advair Diskus, which is used in the treatment of asthma and other respiratory disorders. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - May 17, 2020 Category: Pharmaceuticals Source Type: news
Pharmascience Inc. Launches pms-FLUTICASONE PROPIONATE/SALMETEROL DPI for the Maintenance Treatment of Asthma and COPD
MONTREAL, March 18, 2020 -- (Healthcare Sales & Marketing Network) - Pharmascience Inc. is proud to bring to market a new product for the maintenance treatment of asthma and COPD. pms-FLUTICASONE PROPIONATE/SALMETEROL DPI, a generic alternative to ADVAIR ... Biopharmaceuticals, Generics, Drug Delivery, Product Launch Pharmascience, FLUTICASONE, SALMETEROL, ADVAIR DISKUS, COPD (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - March 18, 2020 Category: Pharmaceuticals Source Type: news
Airduo Digihaler (Fluticasone Propionate and Salmeterol Inhalation Powder) - updated on RxList
(Source: RxList - New and Updated Drug Monographs)
Source: RxList - New and Updated Drug Monographs - March 6, 2020 Category: Drugs & Pharmacology Source Type: news
Lannett Enters Into Distribution Agreement For Generic ADVAIR DISKUS(R)
PHILADELPHIA, Oct. 1, 2019 -- (Healthcare Sales & Marketing Network) -- Lannett Company, Inc. (NYSE: LCI) today announced that it has entered into an exclusive U.S. distribution agreement for the therapeutically equivalent generic of ADVAIR DISKUS® (F... Biopharmaceuticals, Generics, Distribution Lannett Company, ADVAIR DISKUS, Fluticasone Propionate (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - October 1, 2019 Category: Pharmaceuticals Source Type: news
FDA Approves AirDuo Digihaler (fluticasone propionate and salmeterol) Inhalation Powder for Asthma
JERUSALEM and PARSIPPANY, N.J., July 15, 2019– Teva Pharmaceutical Industries Ltd. (NYSE and TASE: TEVA) announced today that the U.S. Food and Drug Administration (FDA) has approved AirDuo® Digihaler™ (fluticasone propionate 113... (Source: Drugs.com - New Drug Approvals)
Source: Drugs.com - New Drug Approvals - July 15, 2019 Category: Drugs & Pharmacology Source Type: news
10 New Drugs for Primary Care: Q1 2019
Highlights: The first liquid solution of colchicine for prophylaxis of gout, the first generic version of Advair Diskus,® and 8 more new and approved drugs. (Source: ConsultantLive)
Source: ConsultantLive - April 11, 2019 Category: Internal Medicine Authors: Sydney Jennings Tags: ADHD Asthma COPD Depression Gout Headache and Migraine HIV AIDS Source Type: news
Wixela Inhub (Fluticasone Propionate and Salmeterol Inhalation Powder) - new on RxList
(Source: RxList - New and Updated Drug Monographs)
Source: RxList - New and Updated Drug Monographs - February 21, 2019 Category: Drugs & Pharmacology Source Type: news
Mylan Launches Advair Generic at One-Third Price Mylan Launches Advair Generic at One-Third Price
Mylan NV on Tuesday priced its generic version of GlaxoSmithKline ' s blockbuster asthma treatment Advair 70 percent lower than the branded medicine.Reuters Health Information (Source: Medscape Allergy Headlines)
Source: Medscape Allergy Headlines - February 15, 2019 Category: Allergy & Immunology Tags: Pulmonary Medicine News Source Type: news
Touting pricetag, Mylan launches Advair generic
Mylan (NSDQ:MYL) today announced the launch of its Wixela Inhub product, a generic for GlaxoSmithKline‘s (NYSE:GSK) Advair Diskus device, for people with asthma or chronic obstructive pulmonary disease.
The company touted that its device’s list price is 70% less than Advair Diskus and 67% less than GSK’s generic.
Get the full story at our sister site, Drug Delivery Business News.
The post Touting pricetag, Mylan launches Advair generic appeared first on MassDevice. (Source: Mass Device)
Source: Mass Device - February 12, 2019 Category: Medical Devices Authors: Sarah Faulkner Tags: Business/Financial News Drug-Device Combinations Featured Food & Drug Administration (FDA) Pharmaceuticals Wall Street Beat GlaxoSmithKline plc Mylan Source Type: news
Mylan's Advair generic starts at one-third price
Mylan ' s generic version of GlaxoSmithKline ’s asthma treatment, the first generic to be launched, is priced 70 percent lower than the blockbuster version. (Source: PharmaManufacturing.com)
Source: PharmaManufacturing.com - February 12, 2019 Category: Pharmaceuticals Source Type: news
Mylan launches Advair generic at one-third price
Mylan NV on Tuesday priced its generic version of GlaxoSmithKline's blockbuster asthma treatment Advair 70 percent lower than the branded medicine. (Source: Reuters: Health)
Source: Reuters: Health - February 12, 2019 Category: Consumer Health News Tags: healthNews Source Type: news
GSK strategy revamp and shingles drug help lift earnings
UK drugmaker warns 2019 earnings likely to be hit by generic rival to Advair asthma drug (Source: FT.com - Drugs and Healthcare)
Source: FT.com - Drugs and Healthcare - February 6, 2019 Category: Pharmaceuticals Source Type: news
